Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Hull

About this trial

This is a single arm feasibility study of exercise for improving long- course neoadjuvant chemoradiotherapy (NACRT) efficacy in people diagnosed with locally advanced rectal cancer. The study aims to recruit up to 30 patients from the Queen's Centre for Oncology and Haematology of Castle Hill Hospital, Cottingham, diagnosed with locally advanced rectal cancer. Consenting patients will be provided with an 11-week course of structured aerobic exercises and resistance training in the periods before, during and after their chemoradiotherapy treatment. The patients will be followed up for 6 months post long course neoadjuvant chemoradiotherapy (NACRT), with a total of 3 assessment periods.

Eligibility criteria

Qualifiers

18 years or older

Have been diagnosed with locally advanced rectal cancer using MRI (Magnetic Resonance Imaging) and histological finding

Have been offered long-course neoadjuvant chemoradiotherapy in the Queens Centre, Castle Hill Hospital

Willing and able to comply with all study requirements

Disqualifiers

Inability to understand basic written and spoken English, as research materials will all be written in English.

Any movement deficiencies limiting ability to engage in exercise.

Impaired cognition and/or capacity limiting ability to provide informed consent.

Cardiovascular and/or cardiopulmonary conditions that will impede ability to safely perform exercise.

Trial design

Treatments tested in this trial

  • Supervised Vigorous intensity aerobic interval exercise

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Hull

Lead sponsor

Hull University Teaching Hospitals NHS Trust

Collaborator